EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation

Suyog Shaha, Danika Rodrigues, Samir Mitragotri

Journal of Controlled Release · 2024-03 · 367 · 737-767

DOI: 10.1016/j.jconrel.2024.01.072 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2024-03. Verfasst von Suyog Shaha und 2 weiteren Autor:innen. Beteiligte Einrichtung: John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA 02134, USA; Wyss Institute for Biologically Inspired Engi…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Neoplasms. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 275 Literaturangaben. Gefördert von: Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University, Harvard School of Engineering and Applied Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic drug delivery is the current clinically preferred route for cancer therapy. However, challenges associated with tumor localization and off-tumor toxic effects limit the clinical effectiveness of this route. Locoregional drug delivery is an emerging viable alternative to systemic therapies. With the improvement in real-time imaging technologies and tools for direct access to tumor lesions, the clinical applicability of locoregional drug delivery is becoming more prominent. Theoretically, locoregional treatments can bypass challenges faced by systemic drug delivery. Preclinically, locoregional delivery of drugs has demonstrated enhanced therapeutic efficacy with limited off-target effects while still yielding an abscopal effect. Clinically, an array of locoregional strategies is under investigation for the delivery of drugs ranging in target and size. Locoregional tumor treatment strategies can be classified into two main categories: 1) direct drug infusion via injection or implanted port and 2) extended drug elution via injected or implanted depot. The number of studies investigating locoregional drug delivery strategies for cancer treatment is rising exponentially, in both preclinical and clinical settings, with some approaches approved for clinical use. Here, we highlight key preclinical advances and the clinical relevance of such locoregional delivery strategies in the treatment of cancer. Furthermore, we critically analyze 949 clinical trials involving locoregional drug delivery and discuss emerging trends.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsNeoplasmsHumansInjections

Stichwörter der Autor:innen

Abscopal effectCancer therapyDepotDrug delivery systemsImplantable portInjectable hydrogelIntratumoralLocalMicroneedlesOmmayaScaffoldTACEWafer

Autor:innen und Institutionen

  • John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA 02134, USA; Wyss Institute for Biologically Inspired Engineering, Boston, MA 02115, USA.
  • John A. Paulson School of Engineering and Applied Sciences, Harvard University, Allston, MA 02134, USA; Wyss Institute for Biologically Inspired Engineering, Boston, MA 02115, USA. Electronic address: mitragotri@seas.ha…

Förderung

  • Hansjörg Wyss Institute for Biologically Inspired Engineering, Harvard University
  • Harvard School of Engineering and Applied Sciences

Zitieren

APA

Shaha, S., Rodrigues, D., & Mitragotri, S. (2024). Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation. Journal of Controlled Release, 367, 737-767. https://doi.org/10.1016/j.jconrel.2024.01.072

Vancouver

Shaha S, Rodrigues D, Mitragotri S. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation. Journal of Controlled Release. 2024;367:737-767. doi:10.1016/j.jconrel.2024.01.072

BibTeX
@article{Shaha2024,
  author = {Shaha, Suyog and Rodrigues, Danika and Mitragotri, Samir},
  title = {Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {367},
  pages = {737--767},
  doi = {10.1016/j.jconrel.2024.01.072}
}
Kostenlos starten →